Article
Dexcom to resubmit G7 glucose monitor software for FDA review, pushing back US launch
Rating:
0.0
Views:
32
Likes:
1
Library:
1
Diabetes tracker developer Dexcom is pushing back the timeline for a U.S. | Diabetes tracker developer Dexcom is pushing back the timeline for a U.S. launch of the latest generation of its continuous glucose monitor, the G7, after the FDA raised questions about the device's software during a review.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value